By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 70
NEW YORK (Reuters Health) – Random blood glucose (RBG) measurements early in pregnancy can identify women with overt diabetes in pregnancy (ODIP), researchers from UK report in the…
NEW YORK (Reuters Health) – New research supports current clinical guidance to perform partial nephrectomy (PN) when possible in patients with clinically organ-confined renal cell tumors 7 centimeters…
NEW YORK (Reuters Health) – Most patients with allergic reactions to clopidogrel do not need to stop the drug or switch to another antiplatelet drug but rather can…
NEW YORK (Reuters Health) – A simple ultrasound examination of the femoral artery puncture site before elective percutaneous coronary intervention decreases the rate of subsequent vascular complications, a…
NEW YORK (Reuters Health) – For preventing relapse of ulcerative colitis (UC), mesalamine can be taken once a day rather than twice or three times daily, according to…
NEW YORK (Reuters Health) – For patients with a limited number of brain metastases, treatment with stereotactic radiosurgery alone is as good as whole-brain radiotherapy plus stereotactic radiosurgery…
NEW YORK (Reuters Health) – Treating patients with ischemic stroke up to 22 hours after onset with the glycoprotein IIb/IIIa platelet receptor antagonist tirofiban does not increase cerebral…
NEW YORK (Reuters Health) – Treating patients with pulmonary arterial hypertension with more than one class of pulmonary vasodilator does not decrease mortality or slow progression of the…
NEW YORK (Reuters Health) – Preterm infants requiring respiratory support do not benefit from inhaled nitric oxide (iNO), according to the results of a meta-analysis of individual patient…
NEW YORK (Reuters Health) – Continuing bivalirudin for 4 hours after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) facilitates early microvascular reperfusion without an…
